Evidence Review
Joint health
Tashiro et al. (2012) conducted one of the longest oral HA trials on record — a 12-month, double-blind, placebo-controlled study in 60 subjects with knee osteoarthritis (Kellgren-Lawrence grade 2 or 3). Participants received 200 mg/day of high molecular weight polymer HA or placebo. Both groups improved on the Japanese Knee Osteoarthritis Measure (JKOM) over 12 months, but the HA group showed a stronger trend — most pronounced in subjects aged 70 or younger, where the difference reached statistical significance. The authors suggested age-related differences in remaining HA synthesis capacity may explain the subgroup effect. Limitations include modest overall effect size and difficulty separating placebo response in subjective pain trials [1].
Wang et al. (2021) tested a low molecular weight liquid HA formulation combined with glucosamine and chondroitin in an 8-week RCT of 40 knee OA patients with mild pain. The combination produced statistically significant improvements in pain (VAS) and physical function (WOMAC) compared to placebo (p < 0.05). Because the intervention combined three agents, HA's individual contribution cannot be isolated from this study, but the combination reflects how these supplements are typically used clinically [2].
A 2025 systematic review (PMID 39886281) pooled findings from 11 clinical studies of oral HA in osteoarthritis and low back pain. Nine of the 11 studies found improvement in at least one outcome — pain, stiffness, or function — versus placebo. The reviewers concluded oral HA shows a favorable risk-benefit profile for joint discomfort, though they noted the need for larger, longer trials.
Skin hydration and wrinkle reduction
Hsu et al. (2021) ran a 12-week, double-blind, placebo-controlled trial in 40 healthy adults (ages 35–64) given 120 mg/day of HA. After 12 weeks, the HA group showed statistically significant improvements across all skin metrics compared to placebo: wrinkle assessment scores, stratum corneum water content, transepidermal water loss (TEWL), and skin elasticity. The reduction in TEWL is notable — it suggests oral HA may be strengthening the skin barrier, not merely boosting surface moisture transiently [3].
Göllner et al. (2017) assessed 20 women aged 45–60 who took a daily oral HA solution for 40 days. Using objective measurement tools, they found significant improvements from baseline in skin elasticity, hydration, surface roughness, and wrinkle depth. The study lacked a placebo group, which is a methodological limitation. However, its quantitative instrument-based measurements and findings consistent with the larger blinded Hsu et al. trial add credibility [4].
Absorption and bioavailability
Kimura et al. (2016) investigated how oral HA is processed, using tracer-labeled HA in animal models alongside human-applicable mechanistic analysis. After ingestion, high molecular weight HA is first fragmented by digestive processes and intestinal bacteria into oligosaccharides (smaller sugar chains). These fragments are then absorbed through the intestinal wall, detectable in serum within 4–8 hours. Tracer studies found HA fragments preferentially accumulated in joint tissue and skin, suggesting tissue-specific uptake after oral dosing [5]. This mechanistic work provides a plausible biological basis for the clinical trial results — oral HA is not simply excreted.
Summary of evidence quality
| Use case |
Evidence strength |
| Knee joint pain / early OA |
Moderate — multiple RCTs, consistent directional signal |
| Skin hydration |
Moderate — placebo-controlled RCT data, consistent across studies |
| Wrinkle reduction |
Moderate — confirmed in double-blind RCT |
| Eye health (oral route) |
Weak — mechanistically plausible, limited direct human trial data |
| Oral bioavailability |
Moderate — mechanistic and tracer studies support absorption |
Overall, HA supplementation is well-tolerated with no significant adverse effects in trials to date. Evidence is most consistent for skin hydration and wrinkle reduction. Joint benefits are real but modest — HA works best as part of a broader approach that includes movement, weight management, and anti-inflammatory nutrition rather than as a standalone treatment for OA.